PRECLINICAL TESTING OF THE EFFICACY AND SAFETY OF CRISPR/CAS9 GENE EDITED CAR-T CELL THERAPY FOR DIFFUSE MIDLINE GLIOMA (DMG)

被引：0
|
作者：
Balakrishnan, Ilango [1 ]
Leach, Lillie [1 ]
Pierce, Angela [1 ]
Lakshmanachetty, Senthilnath [1 ]
Madhavan, Krishna [1 ]
Fosmire, Susan [1 ]
Chatwin, Hannah [1 ]
Green, Adam [1 ]
Fry, Terry [1 ]
Vibhakar, Rajeev [1 ]
Kohler, Eric. M. [1 ]
Venkataraman, Sujatha [1 ]
机构：
[1] Univ Colorado, Aurora, CO USA
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
10.1093/neuonc/noad073.079
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DIPG-32
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Revolutionizing cancer treatment: enhancing CAR-T cell therapy with CRISPR/Cas9 gene editing technology
    Tao, Ruiyu
    Han, Xiaopeng
    Bai, Xue
    Yu, Jianping
    Ma, Youwei
    Chen, Weikai
    Zhang, Dawei
    Li, Zhengkai
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [2] CRISPR/Cas9: A Powerful Strategy to Improve CAR-T Cell Persistence
    Wei, Wei
    Chen, Zhi-Nan
    Wang, Ke
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
  • [3] NOVEL GENE-EDITED CAR-T CELL THERAPY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA
    Balakrishnan, Ilango
    Leach, Lillie
    Lakshmanachetty, Senthilnath
    Pierce, Angela
    Madhavan, Krishna
    Chatwin, Hannah
    Fosmire, Susan
    Meadows, Christina
    Green, Adam
    Fry, Terry
    Vibhakar, Rajeev
    Kohler, Eric M.
    Venkataraman, Sujatha
    NEURO-ONCOLOGY, 2022, 24 : 86 - 86
  • [4] Strengthening the CAR-T cell therapeutic application using CRISPR/Cas9 technology
    Sadeqi Nezhad, Muhammad
    Yazdanifar, Mahboubeh
    Abdollahpour-Alitappeh, Meghdad
    Sattari, Arash
    Seifalian, Alexander
    Bagheri, Nader
    BIOTECHNOLOGY AND BIOENGINEERING, 2021, 118 (10) : 3691 - 3705
  • [5] Applications and explorations of CRISPR/Cas9 in CAR T-cell therapy
    Li, Chenggong
    Mei, Heng
    Hu, Yu
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2020, 19 (03) : 175 - 182
  • [6] Allogeneic CRISPR/Cas9 gene-edited CAR-T cells targeting CD33 show potent cells
    McEwan, Brigid
    Padalia, Zinkal
    Porras, Ashley
    Sagert, Jason
    Terrett, Jonathan A.
    Ho, Tony
    Kalaitzidis, Demetrios
    CANCER RESEARCH, 2019, 79 (13)
  • [7] Overcoming CAR-T Cell Exhaustion and Improving Antitumoral Efficacy in Hematologic Neoplasms Utilizing CRISPR/ Cas9 Technology
    Knoedler, Leonard
    Perl, Markus
    Becker, Luisa
    Poeck, Hendrik
    Schmidl, Christian
    Herr, Wolfgang
    BLOOD, 2022, 140 : 12701 - 12702
  • [8] Combination of CRISPR/Cas9 System and CAR-T Cell Therapy: A New Era for Refractory and Relapsed Hematological Malignancies
    Hu, Ke-jia
    Yin, Elaine Tan Su
    Hu, Yong-xian
    Huang, He
    CURRENT MEDICAL SCIENCE, 2021, 41 (03) : 420 - 430
  • [9] Combination of CRISPR/Cas9 System and CAR-T Cell Therapy: A New Era for Refractory and Relapsed Hematological Malignancies
    Ke-jia Hu
    Elaine Tan Su Yin
    Yong-xian Hu
    He Huang
    Current Medical Science, 2021, 41 : 420 - 430
  • [10] CRISPR/Cas9 Gene-Edited Hematopoietic Stem Cell Therapy for Sickle Cell Disease
    Yu, Vionnie W. C.
    Liu, Yi
    Curran, Matthew
    Zhang, Pu
    Snead, Jennifer
    Schmedt, Christian
    Yang, Yi
    Lin, Victor Guosheng
    Tschantz, William R.
    Quinn, Lisa
    Russ, Carsten
    Clarkson, Scott
    Janiak, Amy
    Stewart, Morag
    Mulumba, Yanick
    Lescarbeau, Reynald
    Murray, Brad
    Seitzer, Jessica
    Strapps, Walter
    Huang, Hon-Ren
    Sloan, Kevin
    Mickanin, Craig S.
    Klickstein, Lloyd
    Stevenson, Susan
    BLOOD, 2017, 130
12345